These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 15642672

  • 1. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
    Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG, Barbui T, Tura S, Baccaranion M, Gruppo Italiano per lo Studio delle Malattie Ematologiche dell'Adulto.
    Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
    [Abstract] [Full Text] [Related]

  • 2. The association between idiopathic thrombocytopenic purpura and cardiovascular disease: a retrospective cohort study.
    Chandan JS, Thomas T, Lee S, Marshall T, Willis B, Nirantharakumar K, Gill P.
    J Thromb Haemost; 2018 Mar; 16(3):474-480. PubMed ID: 29297977
    [Abstract] [Full Text] [Related]

  • 3. Refractory immune thrombocytopenic purpura (ITP) after accessory splenectomy: A case report and literature review.
    Riaz A, Ali HT, Ali F, Ali J.
    Clin Hemorheol Microcirc; 2023 Mar; 85(2):189-194. PubMed ID: 37599530
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up of laparoscopic splenectomy in patients with immune thrombocytopenic purpura.
    Kang CM, Lee JG, Kim KS, Choi JS, Lee WJ, Kim BR, Ko YW, Han JS, Min YH.
    J Korean Med Sci; 2007 Jun; 22(3):420-4. PubMed ID: 17596647
    [Abstract] [Full Text] [Related]

  • 5. Management of patients with refractory immune thrombocytopenic purpura.
    George JN.
    J Thromb Haemost; 2006 Aug; 4(8):1664-72. PubMed ID: 16879206
    [Abstract] [Full Text] [Related]

  • 6. Splenectomy outcomes in immune cytopenias: Treatment outcomes and determinants of response.
    Ogbue OD, Bahaj W, Kewan T, Ahmed R, Dima D, Willimas N, Durmaz A, Visconte V, Maskal SM, Gurnari C, Steven R, Maciejewski JP.
    J Intern Med; 2024 Feb; 295(2):229-241. PubMed ID: 37953670
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of splenectomy in immune thrombocytopenia.
    Mishra K, Kumar S, Sandal R, Jandial A, Sahu KK, Singh K, Ahuja A, Somasundaram V, Kumar R, Kapoor R, Sharma S, Singh J, Yanamandra U, Das S, Chaterjee T, Sharma A, Nair V.
    Am J Blood Res; 2021 Feb; 11(4):361-372. PubMed ID: 34540344
    [Abstract] [Full Text] [Related]

  • 10. How complicated can be a case with immune thrombocytopenic purpura?: postsplenectomy arterial thrombosis.
    Kaya AD, Tekin O, Colak Y, Serin I.
    Blood Coagul Fibrinolysis; 2024 Jun 01; 35(4):209-213. PubMed ID: 38407854
    [Abstract] [Full Text] [Related]

  • 11. Treatments for Primary Immune Thrombocytopenia: A Review.
    Samson M, Fraser W, Lebowitz D.
    Cureus; 2019 Oct 06; 11(10):e5849. PubMed ID: 31754584
    [Abstract] [Full Text] [Related]

  • 12. Sirolimus is effective and safe in childhood relapsed-refractory autoimmune cytopenias: A multicentre study.
    Acar SO, Tahta N, Al IO, Erdem M, Gözmen S, Karapınar TH, Kılınç B, Celkan T, Kirkiz S, Koçak Ü, Ören H, Yıldırım AT, Arslantaş E, Ayhan AC, Oymak Y.
    Scand J Immunol; 2024 Aug 06; 100(2):e13376. PubMed ID: 38741164
    [Abstract] [Full Text] [Related]

  • 13. [Quantity of Treg cells and Th17 cells in spleen of primary immune thrombocytopenic purpura patients].
    Yang YY, Zhang FQ, Pan Y, Chen F, Huang MJ, Zeng DY, Huang HG.
    Zhonghua Xue Ye Xue Za Zhi; 2017 Mar 14; 38(3):227-230. PubMed ID: 28395447
    [Abstract] [Full Text] [Related]

  • 14. Protective effects of COVID-19 vaccination in splenectomized patients with immune thrombocytopenia.
    Liu X, Gan X, Xu J, Wang Y, Huang J, He X, Li Y, Gong Y, Peng B, Niu T.
    Br J Haematol; 2024 Jun 14; 204(6):2217-2221. PubMed ID: 38632670
    [Abstract] [Full Text] [Related]

  • 15. Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.
    Ruggeri M, Tosetto A, Palandri F, Polverelli N, Mazzucconi MG, Santoro C, Gaidano G, Lunghi M, Zaja F, De Stefano V, Sartori R, Fazi P, Rodeghiero F, Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Anemia and Thrombocytopenias Working Party. GIMEMA Study ITP0311.
    J Thromb Haemost; 2014 Aug 14; 12(8):1266-73. PubMed ID: 24942752
    [Abstract] [Full Text] [Related]

  • 16. Study of platelet kinetics in immune thrombocytopenia to predict splenectomy response.
    Mendoza A, Álvarez-Román MT, Monzón-Manzano E, Acuña P, Arias-Salgado EG, Rivas-Pollmar I, Martín-Salces M, Martínez de Miguel B, Martínez Montalbán E, Jiménez-Yuste V, Butta N.
    Br J Haematol; 2024 Jan 14; 204(1):315-323. PubMed ID: 37822168
    [Abstract] [Full Text] [Related]

  • 17. Rituximab versus Splenectomy in Chronic Primary ITP: Experience of a Single Hematology Clinic.
    Shamoon RP, Yassin AK, Alnuaimy SL.
    Mediterr J Hematol Infect Dis; 2024 Jan 14; 16(1):e2024019. PubMed ID: 38468837
    [Abstract] [Full Text] [Related]

  • 18. A retrospective analysis of 122 immune thrombocytopenia patients treated with dapsone: Efficacy, safety and factors associated with treatment response.
    Colella MP, Orsi FA, Alves ECF, Delmoro GF, Yamaguti-Hayakawa GG, de Paula EV, Annichino-Bizzacchi JM.
    J Thromb Haemost; 2021 Sep 14; 19(9):2275-2286. PubMed ID: 34018665
    [Abstract] [Full Text] [Related]

  • 19. [Efficacy of decitabine in patients with glucocorticoid-resistant primary immune thrombocytopenia: factors influencing treatment responses].
    Yang JH, Xue MJ, Zhang XL, Wei ZC, Shao LL, Shi Y, Hou M.
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jul 14; 44(7):567-571. PubMed ID: 37749037
    [Abstract] [Full Text] [Related]

  • 20. First-in-patient study of hetrombopag in patients with chronic idiopathic thrombocytopenic purpura.
    Wang Z, Chen L, Zhang F, Lu H, Chen X, Wen A, Luo J, Hu Y, Wang Y, Niu T, Zheng L.
    J Thromb Haemost; 2020 Nov 14; 18(11):3053-3060. PubMed ID: 32865293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.